Researcher

Gregory Y.H. Lip

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

JUL 11, 2026 · JOURNAL ARTICLE

Safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy

Expert Opinion on Drug Safety

A narrative review synthesizing evidence on DOAC safety and efficacy in complex AF phenotypes, offering expert recommendations for individualized care rather than reporting a single original empirical result.

Expert GuidanceHeart Failure Treatment and Management Gregory Y.H. Lip Panteleimon E. Papakonstantinou

Study details

DesignNarrative review

InterventionDirect oral anticoagulants (DOACs)

ComparatorVitamin K antagonists (warfarin) and other…

JUL 2, 2026 · JOURNAL ARTICLE

Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association

Stroke

A scientific statement synthesizing evidence on anticoagulation management in LV dysfunction without intracardiac thrombus, providing best practice recommendations rather than presenting new primary data.

Expert GuidanceGlenn N. Levine Cardiac Tumors and Thrombi Sarah A. Spinler

Reported

LV systolic dysfunction definitionreduced LV ejection fraction ≤40% or left w…